Author

Kartik Singhal

Washington University in St. LouisORCID 0000-0002-3855-7950Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Malachi GriffithiD· 2 shared Obi L. GriffithiD· 2 shared Robert D. SchreiberiD· 2 shared Todd A. FehnigeriD· 2 shared Alexander BagaeviD· 1 shared Amanda F. CasheniD· 1 shared Anthony N. VomundiD· 1 shared Brad S. KahliD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Malachi GriffithORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Personalized Neoantigen Vaccines Synergize with Immune Checkpoint Therapy and CD8-Targeted Cytokines to Control B-Cell Lymphoma

Yuang Song, Ekaterina Aladyeva, Ruan F.V. Medrano, Derek J. Theisen, Cora D. Arthur, J. Michael White, Heather N. Kohlmiller, Anthony N. Vomund, Kartik Singhal, My Hoang, Samuel Ameh, Kathleen C. F. Sheehan, Ronald Levy, Todd A. Fehniger, Maxim N. Artyomov, , Robert D. Schreiber

This study shows that personalized neoantigen vaccines combined with immune checkpoint therapy and CD8-targeted cytokines effectively control B-cell lymphoma by enhancing T-cell responses and preventing dysfunction.

bioRxiv · Aug 6, 2026 · PreprintImmunology

Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma

Cody A. Ramirez, Michelle Becker‐Hapak, Kartik Singhal, David A. Russler‐Germain, Felix E. Frenkel, Erica Kay Barnell, Ethan D. McClain, Sweta Desai, Timothy Schappe, Onyinyechi C. Onyeador, Olga M. Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, , Todd A. Fehniger

This study identifies high-quality neoantigens in follicular lymphoma patients using WES and RNA-Seq, and initiates a clinical trial of personalized neoantigen vaccines combined with PD-1 blockade.

Blood Advances · May 7, 2024Peer-reviewedGenetic & Genomic Medicine